Department of Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.
Dis Colon Rectum. 2011 Jan;54(1):95-100. doi: 10.1007/DCR.0b013e3181f46810.
Sacral neuromodulation is a well researched and successful treatment for functional bowel disorders. Indications have expanded throughout the years and various studies have been published on clinical efficacy or on technique improvement. The main goal of this retrospective study was to systematically evaluate daily experiences with this treatment and measure the long-term satisfaction of sacral neuromodulation therapy for functional bowel disorders.
After institutional review board approval a new, self-designed postal questionnaire was sent to all patients in our center who were being treated with sacral neuromodulation. Only patients with a minimal follow-up of 1 year were included in the survey. Implantation years range from 2000 to 2007.
A total of 174 patients received the questionnaire regarding patient satisfaction and experience with sacral neuromodulation therapy. The response rate after reminder letter was 71.8% (n = 125) including 114 (91.2%) females. Patient satisfaction was high: 81 patients (65.3%) reported their results as very satisfying, 30 patients (24.2%) were moderately satisfied, and 13 patients (10.4%) were not satisfied. Analysis showed that patient satisfaction can be explained by both patient perception of present bowel function and their evaluation of the quality of daily life. No significant relationship was found with patient demographics, self-ascribed (co)morbidity, behavioral habits, or therapy duration. A total of 47 patients (38.2%) reported having some concerns regarding the future with sacral neuromodulation treatment. Twenty-eight patients (23.1%) reported a temporary loss of effect at any time during sacral neuromodulation therapy. Pain at the implantation site was reported by 65 patients (52.4%).
This study shows that patients treated with sacral neuromodulation, in general, are very satisfied. The main problems mentioned by patients are pain, loss of efficacy, and general concerns.
骶神经调节是一种经过充分研究且行之有效的治疗功能性肠病的方法。多年来，其适应证不断扩大，并且已经发表了许多关于临床疗效或技术改进的研究。本回顾性研究的主要目的是系统评估该治疗方法的日常体验，并测量功能性肠病患者对骶神经调节治疗的长期满意度。
在获得机构审查委员会批准后，我们向中心接受骶神经调节治疗的所有患者发送了一份新的、自行设计的邮寄问卷。只有接受至少 1 年随访的患者才被纳入该调查。植入年份范围为 2000 年至 2007 年。
共有 174 名患者收到了关于骶神经调节治疗患者满意度和体验的问卷。在发出提醒信后，应答率为 71.8%（n=125），包括 114 名（91.2%）女性。患者满意度很高：81 名患者（65.3%）报告其结果非常满意，30 名患者（24.2%）满意，13 名患者（10.4%）不满意。分析表明，患者满意度既可以通过患者对现有肠道功能的感知来解释，也可以通过他们对日常生活质量的评估来解释。患者人口统计学特征、自认为的（共）患病情况、行为习惯或治疗持续时间与患者满意度均无显著关系。共有 47 名患者（38.2%）对骶神经调节治疗的未来存在一些担忧。28 名患者（23.1%）报告在骶神经调节治疗期间任何时候都出现了暂时的疗效丧失。65 名患者（52.4%）报告了植入部位疼痛。
本研究表明，接受骶神经调节治疗的患者总体上非常满意。患者提到的主要问题是疼痛、疗效丧失和普遍担忧。
Zotero 插件